Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.

It has been about a month since the last earnings report for Labcorp Holdings (LH). Shares have added about 8.1% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Gilead Sciences hired Bristol Myers Squibb alum Bob Allen as head of omnichannel strategy and digital transformation for public affairs. Ralph Abraham, who is Louisiana ‘s surgeon general, has been ...

While Labcorp Holdings has underperformed the S&P 500 Index slightly over the past year, its YTD strength stands out.

Labcorp Holdings announced the appointment of Victor Bulto, President of Novartis U.S., to its Board of Directors, effective December 1, 2025. Bulto brings extensive experience in healthcare ...

Labcorp shares edge higher as new studies spotlight Plasma Detect's role in tracking MRD and improving post-surgery cancer detection.

Labcorp Holdings Inc's (NYSE: LH) short interest as a percent of float has risen 10.21% since its last report. According to ...

A high-tech menstrual cup developed by a Bristol entrepreneur has secured £6.8m in a seed funding round. Emm is a wearable ...

Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global ...

AABB-accredited DNA testing is the standard when results need to stand up in court or be accepted by government agencies. If ...

Sandoz’s Tyruko (natalizumab), the only FDA approved natalizumab biosimilar for adults with relapsing multiple sclerosis and Crohn’s disease, is now available by prescription in the United States ...

Last week, readers were most interested in a story about Labcorp's acquisition of certain lab assets of Parkview Health, which serves patients in Indiana and northwest Ohio.